Pharmacogenetics, Pharmacoepigenetics and Personalized Medicine in Children (R01)
The summary for the Pharmacogenetics, Pharmacoepigenetics and Personalized Medicine in Children (R01) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Pharmacogenetics, Pharmacoepigenetics and Personalized Medicine in Children (R01): The purpose of this funding opportunity announcement (FOA) is to encourage pharmacogenetic and epigenetic studies and improved phenotypingin childrens pharmacotherapy that will allow individualization of treatment in children.
Federal Grant Title: | Pharmacogenetics, Pharmacoepigenetics and Personalized Medicine in Children (R01) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health Income Security and Social Services |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PAR-14-274 |
Type of Funding: | Grant |
CFDA Numbers: | 93.865 |
CFDA Descriptions: | Child Health and Human Development Extramural Research |
Current Application Deadline: | Sep 7, 2017 |
Original Application Deadline: | Sep 7, 2017 |
Posted Date: | Jul 2, 2014 |
Creation Date: | Jul 2, 2014 |
Archive Date: | Oct 8, 2017 |
Total Program Funding: | |
Maximum Federal Grant Award: | none |
Minimum Federal Grant Award: | none |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
County governments
Public and State controlled institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
Native American tribal governments (Federally recognized)
Independent school districts
Private institutions of higher education
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Special district governments
Small businesses
For profit organizations other than small businesses
State governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Additional Information on Eligibility
- Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Foreign Institutions
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. - Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/pa-files/PAR-14-274.html
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
National Institutes of Health 301-496-3405 - Similar Government Grants
- • Development of Novel Nonsteroidal Contraceptive Methods (R61/R33 - Clinical Trial Not Allo...
- • National Centers for Translational Research in Reproduction and Infertility (NCTRI) (P50 C...
- • Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescen...
- • Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed)
- • Biological Testing Facility (X01 Clinical Trial Not Allowed)
- • Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Precli...
- • Phase II Small Business Innovation Research Renewal Awards for Device Assessment or Precli...
- • Reproductive Genetics and Epigenetics
- More Grants from the National Institutes of Health
- • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...
- • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...
- • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...
- • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
- • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...